https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.983505/full
Frontiers | Randomized, placebo-controlled, single-blind phase 1 studies of the safety,...
Background: BRII-196 and BRII-198 are two anti-SARS-CoV-2 monoclonal neutralizing antibodies as a cocktail therapy for treating COVID-19 with a modified Fc r...
phase 1 studiesplacebo controlledsingle blind